Conditions › Benign hereditary telangiectasia

Benign Hereditary Telangiectasia – Specialist Vascular Skin Treatment in London

Benign hereditary telangiectasia (BHT) describes fine, permanent “thread-vein” blood vessels on the skin that run in families and typically begin in childhood or early adulthood. Unlike hereditary haemorrhagic telangiectasia (HHT), BHT does not cause nosebleeds, internal organ malformations or anaemia, and it remains confined to the skin. At Skinhorizon we confirm the diagnosis, rule out important look-alikes and plan targeted vascular laser or IPL to clear visible vessels while protecting your skin tone.

At-a-Glance Summary
What is Benign Hereditary Telangiectasia? An inherited tendency to develop fine, blanchable red telangiectases (thread veins) on the skin without internal organ involvement or frequent nosebleeds.
Key signs of Benign Hereditary Telangiectasia Multiple tiny, bright-red lines or dots that blanch with pressure; often on face, lips, upper trunk and limbs; stable or slowly increasing with age; no mucosal bleeding.
Who gets Benign Hereditary Telangiectasia? Runs in families; males and females; appears from childhood to early adulthood; occurs across all skin tones (visibility varies by pigmentation).
Why Benign Hereditary Telangiectasia matters Cosmetic burden and diagnostic confusion with conditions such as HHT, rosacea, essential telangiectasia or steroid-related change; correct diagnosis guides safe, effective treatment.
Treatment options for Benign Hereditary Telangiectasia Vascular lasers (PDL 595 nm, KTP 532 nm, Nd:YAG 1064 nm for deeper/larger vessels), IPL, occasional electrosurgery; sun protection and camouflage as adjuncts.

What Is Benign Hereditary Telangiectasia?

Benign hereditary telangiectasia (BHT) is a lifelong tendency to develop small, permanently dilated blood vessels (telangiectases) on the skin. These look like fine red threads or tiny “ink-red” dots that blanch when pressed and refill when the pressure is lifted. They often cluster on the cheeks, around the nose, on the lips, neck, upper chest and upper arms, but they can appear anywhere on the body surface. The pattern is stable or slowly progressive and typically begins in childhood or early adult life.

As its name emphasises, BHT is benign. It does not affect internal organs, does not produce recurrent nosebleeds and does not predispose to anaemia or arteriovenous malformations. That makes it quite different from hereditary haemorrhagic telangiectasia (HHT), a separate condition involving fragile blood vessels in the nose and internal organs. Many people with BHT seek care because of appearance concerns or because the diagnosis has been unclear.

How BHT Presents

  • Lesion appearance: tiny, bright red puncta and linear vessels forming a “mat” of fine threads; lesions blanch with pressure and may have a delicate star-burst shape.
  • Distribution: face (cheeks, nose, lips), neck, upper chest and arms; less commonly lower limbs. Mucosal surfaces are typically spared.
  • Course: new telangiectases may appear gradually; existing ones are persistent unless treated with energy-based devices.
  • Symptoms: usually asymptomatic; occasionally mild warmth or flushing. There is no spontaneous bleeding from the skin in uncomplicated BHT.
  • Family history: often positive. The trait can appear across several relatives and generations.

Why Benign Hereditary Telangiectasia Happens

BHT is thought to follow an inherited pattern, most often autosomal dominant (a tendency passed from an affected parent to children). The precise genes are not routinely tested in clinical practice because management is guided by the phenotype (what we see) rather than a laboratory result. Environmental factors—particularly sun exposure, heat and alcohol—may make vessels more visible by promoting facial flushing and superficial vessel dilation; however, these factors are not the root cause.

How We Distinguish BHT from Look-Alikes

Several conditions feature visible blood vessels. Getting the label right avoids unnecessary worry or investigation and directs you to the treatments that actually work.

  • Hereditary haemorrhagic telangiectasia (HHT): telangiectases on lips, tongue, oral/nasal mucosa; recurrent nosebleeds, iron-deficiency anaemia; family history of AVMs (lungs, liver, brain). BHT lacks these systemic features.
  • Rosacea (erythematotelangiectatic): central facial redness, flushing, sensitivity, sometimes papules/pustules. Vessels often overlay a background of redness; triggers include heat, spicy food and alcohol.
  • Generalised essential telangiectasia: progressive red networks on lower limbs and trunk, often in middle-aged adults, without strong family history.
  • Poikiloderma of Civatte: net-like red-brown changes and thinning on the sides of the neck/chest due to sun + fragrance sensitivity; sparing under the chin; a mix of pigment, telangiectasia and slight atrophy.
  • Steroid-related or photodamage telangiectasia: fine vessels in skin thinned by topical steroids or chronic sun exposure.
  • Ataxia-telangiectasia / connective-tissue diseases: rare systemic conditions with neurological or autoimmune signs; not a cosmetic telangiectasia pattern.
  • Spider angiomas & cherry angiomas: focal vascular lesions with different shapes and behaviour; managed similarly with vascular lasers where desired.

At consultation we take a careful history (age at onset, family history, bleeding symptoms, triggers) and examine the pattern under bright light and dermoscopy. This magnified view shows the calibre and arrangement of vessels and helps us separate BHT from inflammatory or pigment conditions.

Treat Hereditary Telangiectasia in Central London

Consultant-led diagnosis and laser treatment in Maida Vale for facial or body thread veins caused by benign hereditary telangiectasia (BHT).

Call Us Book Consultation

Do I Need Tests or Scans for Benign Hereditary Telangiectasia?

In straightforward cases, no tests are required. If someone has features suggestive of HHT (frequent nosebleeds, mouth/nasal telangiectases, family history of AVMs), we advise onward evaluation with their usual healthcare providers. For isolated cutaneous BHT without bleeding or systemic clues, additional investigations are usually unnecessary.

Treatment Options

BHT vessels do not disappear with creams. Effective treatment uses light-based energy that targets oxyhaemoglobin (the red pigment in blood) to seal or collapse visible vessels while sparing surrounding skin. We tailor wavelength, pulse configuration and cooling to your vessel size, depth, skin tone and treatment area.

Pulsed Dye Laser (PDL, ~595 nm)

The established workhorse for fine, superficial facial telangiectases. PDL energy is well absorbed by blood; modern devices allow purpura-free settings (minimal bruising) for many cases. Expect temporary redness and swelling for 24–48 hours; transient small purple spots can occur if purpuric settings are chosen for tougher vessels. Several sessions are usually needed, spaced 4–8 weeks apart.

KTP Laser (532 nm)

Excellent for small, bright-red vessels and discrete spider angiomas. The shorter wavelength targets superficial vasculature precisely; epidermal cooling is important, particularly in lighter Fitzpatrick types (I–III). Downtime is modest.

Nd:YAG (1064 nm)

Penetrates more deeply and can treat slightly larger or deeper blue-tinged vessels, selected leg telangiectases and areas that respond poorly to shorter wavelengths. Because it travels deeper, careful parameter selection and experienced hands are essential to avoid pigment change or scabbing.

Intense Pulsed Light (IPL)

A broad-spectrum light source with vascular filters. Useful when there is a mix of redness, flushing and pigment. IPL can complement lasers in blended facial redness or poikiloderma patterns.

Electrosurgery / Thermocoagulation

Fine-tip cautery can close individual vessels, particularly on the trunk, though it risks pinpoint marks if overused. We tend to prefer light-based options for the face due to superior blending and predictability.

How Many Sessions Will I Need?

Most people need a course of 2–4 sessions for a meaningful clearance, sometimes more for extensive networks or body sites. Because the inherited tendency remains, maintenance every 12–24 months is common, especially for facial areas exposed to sun or heat. We photograph before/after so progress is tracked objectively.

Downtime, Comfort & Aftercare

  • Immediately after: treated areas look red and slightly puffy; a cool pack and elevation help. Makeup can usually be applied the next day for facial work.
  • Skin care: keep it simple for a few days—fragrance-free cleanser, bland emollient, and daily SPF 30+ on exposed sites. Avoid exfoliants/retinoids until redness settles.
  • Activity: avoid saunas, hot yoga, vigorous exercise and alcohol for 24–48 hours to prevent re-dilating vessels.
  • Colour change: temporary darkening or tiny purple dots can occur; they fade over days to two weeks depending on settings and site.

Skin of Colour Considerations

All skin tones can be treated. In medium to deep complexions (Fitzpatrick IV–VI), we choose longer wavelengths (e.g., 595 nm with cooling or 1064 nm for selected targets), conservative fluence and meticulous skin cooling to protect the epidermis. We also emphasise pre- and post-procedure photoprotection to minimise temporary post-inflammatory hyperpigmentation. Test spots are useful when vessels sit over background pigmentation.

What Results Can I Expect?

Facial thread-veins usually respond very well, with visible softening after the first session and continued improvement over a course. Trunk and limb telangiectases can need more passes or different wavelengths. Clearance is measured in terms of cosmetic blending rather than absolute eradication—our goal is that vessels are no longer noticeable in conversation distance or photography. Because the genetic tendency persists, new vessels can appear with time; brief touch-ups maintain results.

Prevention & Everyday Strategies

  • Photoprotection: daily SPF 30+ and shade on sunny days reduce UV-induced vessel prominence and protect laser gains.
  • Heat & flushing management: moderating very hot drinks, saunas and intense heat exposure may help highly flush-prone faces.
  • Skincare: fragrance-minimal routines and gentle cleansers support barrier health; harsh scrubs worsen redness.
  • Camouflage techniques: green-tint primers or medical camouflage can mask residual redness for events.

When to Seek Further Assessment

Arrange review if you notice features not typical of BHT:

  • Recurrent nosebleeds, mouth or nasal telangiectases, or a family history of internal AVMs (consider HHT evaluation).
  • Sudden clusters of vessels around a new, inflamed rash (may indicate another skin condition that needs treatment).
  • Non-blanching red-purple spots that do not fade with pressure (these are not telangiectases and require assessment).

Why Choose Skinhorizon?

We provide high-quality advanced dermatology and aesthetic services with consultant oversight. For hereditary telangiectasia, precision matters: accurate diagnosis to avoid unnecessary investigations, vessel-specific laser selection (PDL/KTP/Nd:YAG/IPL), energy settings tailored to your skin tone and vessel depth, and clear aftercare to keep downtime minimal. We plan realistic courses with maintenance options and photograph results so you can see the objective change.

Your First Visit — What to Expect

  1. Assessment: detailed history (family pattern, symptoms, triggers) and dermoscopic examination to confirm BHT and exclude look-alikes.
  2. Treatment plan: wavelength selection, estimated number of sessions, interval spacing and expected recovery.
  3. Test spots (if needed): particularly for skin of colour or body sites with mixed vessels.
  4. Treatment: optional same-day session for focused areas; cooling and precise pulse delivery for comfort.
  5. Aftercare & follow-up: simple care plan, photo review at each visit, and discussion of maintenance timing once clearance is achieved.

Reviewed by: Dr Mohammad Ghazavi, Consultant Dermatologist

Skinhorizon Clinic, 4 Clarendon Terrace, Maida Vale, London W9 1BZ

Last reviewed:

Discuss candidacy and a tailored plan to clear hereditary telangiectasia with targeted vascular laser or IPL.

Call Us Book Consultation

← Back to Skin Conditions

Frequently Asked Questions

Is benign hereditary telangiectasia the same as HHT?
No. BHT affects the skin only and does not cause nosebleeds or internal organ malformations. HHT involves mucosal bleeding and arteriovenous malformations; it needs specific medical assessment.
Will creams get rid of the thread-veins?
No. Topical products cannot remove telangiectases. Vascular lasers or IPL are the effective options; camouflage can mask redness temporarily.
How many sessions do I need?
Most people need 2–4 sessions for good clearance, spaced 4–8 weeks apart. Maintenance top-ups every 12–24 months help keep results as new vessels may appear with time.
Is treatment painful?
Discomfort is brief and often described as an elastic-band flick. We use cooling and parameter choices to maximise comfort. Over-the-counter analgesia is rarely needed afterwards.
Is it safe for darker skin tones?
Yes, with careful wavelength selection (often 595 nm with strong cooling or 1064 nm for deeper targets), conservative settings, and strict sun protection. We may do test spots first.
Can the vessels come back?
Treated vessels usually stay closed, but your genetic tendency can produce new ones over time. Brief maintenance sessions keep the complexion even.
Do I need blood tests or scans?
Not for typical BHT without bleeding symptoms. If you have frequent nosebleeds or family history of AVMs, we’ll advise appropriate evaluation with your usual healthcare provider.
What’s the downtime?
Expect redness and mild swelling for 24–48 hours. Small purple dots can appear if stronger settings are required; these fade over days to two weeks. Makeup is usually fine the next day for facial areas.
Disclaimer: The information above is provided for general education only and should not be taken as medical advice for any individual case. A consultation with a qualified healthcare professional is required to assess suitability, risks, and expected outcomes.
WhatsApp